Allergan

Evolus' Botox competitor is here. Will it dent Allergan's sales?
Evolus' Botox competitor is here. Will it dent Allergan's sales?
Fierce Pharma
Allergan
Botox
Evolus
Jeuveau
Flag link:
Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Fierce Pharma
Allergan
Botox
Amgen
Eli Lilly
Teva Pharmaceuticals
migraines
Flag link:
Allergan sheds $4.5B in market cap on 4Q18 earnings
Allergan sheds $4.5B in market cap on 4Q18 earnings
BioCentury
Allergan
earnings
Flag link:
Is the Smoldering NASH Market Ready to Burst Into Flames?
Is the Smoldering NASH Market Ready to Burst Into Flames?
BioSpace
NASH
Allergan
Regeneron
Alnylam
AstraZeneca
Merck
Takeda
Gilead Sciences
Bristol-Myers Squibb
Intercept Pharmaceuticals
Flag link:
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Endpoints
Aurinia Pharmaceuticals
voclosporin
eye health
dry eye disease
Allergan
Restasis
Flag link:
Tribe, Allergan appeal sovereign immunity patent case to Supreme Court
Tribe, Allergan appeal sovereign immunity patent case to Supreme Court
BioCentury
Allergan
Supreme Court
inter partes review
Flag link:
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Flag link:
Report: Pharma companies kick off new year with price hikes
Report: Pharma companies kick off new year with price hikes
Drug Delivery Business News
Allergan
Bristol-Myers Squibb
Biogen
Pfizer
drug pricing
Flag link:
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
Fierce Pharma
Takeda
Shire
Allergan
chronic idiopathic constipation
Motegrity
Flag link:
NASH drugs come into focus as field awaits late-stage data
NASH drugs come into focus as field awaits late-stage data
BioSpace
NASH
Intercept Pharma
Gilead Sciences
Genfit
Allergan
Flag link:
Allergan nixes Texas plant expansion as Restasis generics loom
Allergan nixes Texas plant expansion as Restasis generics loom
Fierce Pharma
Allergan
drug manufacturing
Restasis
generics
Flag link:
Allergan axes expansion plan, but reiterates commitment to Waco plant
Allergan axes expansion plan, but reiterates commitment to Waco plant
BioPharma Dive
Allergan
drug manufacturing
Flag link:
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Flag link:
Trump wants drug commercials to include prices. These five companies have the most at stake
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Donald Trump
drug ads
drug pricing
Pfizer
AbbVie
Eli Lilly
Amgen
Allergan
Flag link:
FDA approves five-year hormonal contraceptive
FDA approves five-year hormonal contraceptive
Drug Delivery Business News
Allergan
Medicines360
FDA
contraceptives
Liletta
IUD
Flag link:
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
Fierce Pharma
China
Allergan
Flag link:
Allergan, Sosei halt Alzheimer’s trials amid safety scare
Allergan, Sosei halt Alzheimer’s trials amid safety scare
Fierce Biotech
Allergan
Sosei
HTL0018318
clinical trials
Alzheimer's disease
Flag link:
Allergan fills out medical aesthetics pipeline with $195M Bonti deal
Allergan fills out medical aesthetics pipeline with $195M Bonti deal
Biopharma Dive
Allergan
Bonti
M&A
medical aesthetics
Flag link:
Allergan Unveils Spotlyte, Its First Digital Ventures Launch
Allergan Unveils Spotlyte, Its First Digital Ventures Launch
Market Realist
Allergan
digital ventures
aesthetics
Flag link:
BIO, Allergan and Roche Call for FDA Flexibility With Patient Experience Data
BIO, Allergan and Roche Call for FDA Flexibility With Patient Experience Data
RAPS.org
BIO
Allergan
Roche
FDA
patient experience data
Flag link:

Pages